Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Mitek Systems
MITK
$831M
| $666K | ﹤0.01% |
34,559
-45,387
| -57% | -$764K |
|
|
MSGN
3302
DELISTED
MSG Networks Inc.
MSGN
| $665K | ﹤0.01% |
45,626
-50,556
| -53% | -$786K |
|
3303
Cactus
WHD
$5.78B
| $661K | ﹤0.01% |
18,021
+463
| +3% | +$16K |
|
3304
BlackRock Health Sciences Trust II
BMEZ
$1.01B
| $660K | ﹤0.01% |
22,818
-96,588
| -81% | -$2.67M |
|
3305
Camden National
CAC
$983M
| $660K | ﹤0.01% |
13,827
-151
| -1% | -$7.18K |
|
3306
NVE Corp
NVEC
$584M
| $658K | ﹤0.01% |
8,875
+1,200
| +16% | +$85.5K |
|
3307
Ocugen
OCGN
$468M
| $655K | ﹤0.01% |
81,558
+56,800
| +229% | +$479K |
|
|
PMO
3308
Franklin Municipal Opportunities Trust
PMO
$286M
| $654K | ﹤0.01% |
45,740
-1,014
| -2% | -$14.1K |
|
3309
RCI Hospitality Holdings
RICK
$212M
| $654K | ﹤0.01% |
9,870
+4,435
| +82% | +$311K |
|
3310
Primis Financial Corp
FRST
$407M
| $648K | ﹤0.01% |
42,434
-1,217
| -3% | -$18.3K |
|
3311
Li Auto
LI
$12.3B
| $647K | ﹤0.01% |
+18,514
| New | +$434K |
|
|
HTD
3312
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$910M
| $644K | ﹤0.01% |
25,863
+2,239
| +9% | +$54.7K |
|
3313
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.22B
| $643K | ﹤0.01% |
21,444
-1,349
| -6% | -$41K |
|
3314
Vir Biotechnology
VIR
$1.51B
| $641K | ﹤0.01% |
13,552
+105
| +0.8% | +$4.77K |
|
|
NAGE
3315
Niagen Bioscience
NAGE
$244M
| $635K | ﹤0.01% |
64,419
+36,275
| +129% | +$316K |
|
3316
Stellantis
STLA
$20.3B
| $633K | ﹤0.01% |
32,091
+9,621
| +43% | +$181K |
|
3317
SSR Mining
SSRM
$6.65B
| $629K | ﹤0.01% |
+40,320
| New | +$678K |
|
|
JRO
3318
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $629K | ﹤0.01% |
64,310
+15,870
| +33% | +$151K |
|
3319
Coeur Mining
CDE
$19.4B
| $628K | ﹤0.01% |
70,810
-14,240
| -17% | -$137K |
|
3320
IMAX
IMAX
$2.79B
| $624K | ﹤0.01% |
29,011
+5,293
| +22% | +$114K |
|
3321
Star Group
SGU
$419M
| $618K | ﹤0.01% |
55,200
| – | – |
|
3322
Horizon Technology Finance
HRZN
$329M
| $616K | ﹤0.01% |
35,654
-1,216
| -3% | -$20.1K |
|
3323
JPMorgan Diversified Return US Mid Cap Equity ETF
JPME
$478M
| $614K | ﹤0.01% |
6,991
-641
| -8% | -$55.8K |
|
3324
Reynolds Consumer Products
REYN
$5.48B
| $614K | ﹤0.01% |
20,224
-14,571
| -42% | -$442K |
|
|
TSC
3325
DELISTED
TriState Capital Holdings, Inc.
TSC
| $612K | ﹤0.01% |
30,019
+3,500
| +13% | +$79.8K |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.